Order Article Reprints

Gascón-Ruiz M, Ramírez-Labrada A, Lastra R, Martínez-Lostao L, Paño-Pardo JR, Sesma A, Zapata-García M, Moratiel A, Quílez E, Torres-Ramón I, et al. A Subset of PD-1-Expressing CD56^bright NK Cells Identifies Patients with Good Response to Immune Checkpoint Inhibitors in Lung Cancer. Cancers. 2023; 15(2):329. https://doi.org/10.3390/cancers15020329

Gascón-Ruiz, Marta, Ariel Ramírez-Labrada, Rodrigo Lastra, Luis Martínez-Lostao, J. Ramón Paño-Pardo, Andrea Sesma, María Zapata-García, Alba Moratiel, Elisa Quílez, Irene Torres-Ramón, and et al. 2023. "A Subset of PD-1-Expressing CD56^bright NK Cells Identifies Patients with Good Response to Immune Checkpoint Inhibitors in Lung Cancer" Cancers 15, no. 2: 329. https://doi.org/10.3390/cancers15020329

Gascón-Ruiz, M., Ramírez-Labrada, A., Lastra, R., Martínez-Lostao, L., Paño-Pardo, J. R., Sesma, A., Zapata-García, M., Moratiel, A., Quílez, E., Torres-Ramón, I., Yubero, A., Domingo, M. P., Esteban, P., Gálvez, E. M., Pardo, J., & Isla, D. (2023). A Subset of PD-1-Expressing CD56^bright NK Cells Identifies Patients with Good Response to Immune Checkpoint Inhibitors in Lung Cancer. Cancers, 15(2), 329. https://doi.org/10.3390/cancers15020329